Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration
Authors:
- Evelyne Jacqz-AigrainEJEvelyne Jacqz-Aigrain
- Wei ZhaoWZWei Zhao
- Mike SharlandMSMike Sharland
- John N. van Den AnkerJAJohn N. van Den Anker
- 1 February 2013
- journal article
- review article
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 18 (1) , 28-34
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Intrapartum Evidence of Early-Onset Group B StreptococcusObstetrics & Gynecology, 2012
- Risk factors and prevention of late-onset sepsis in premature infantsEarly Human Development, 2010
- Early and Late Onset Sepsis in Late Preterm InfantsThe Pediatric Infectious Disease Journal, 2009
- Group B Streptococcus and Early-Onset Sepsis in the Era of Maternal ProphylaxisPediatric Clinics of North America, 2009
- A literature review on off-label drug use in childrenEuropean Journal of Pediatrics, 2005
- The use of unlicensed and off-label medicines in the neonateSeminars in Fetal and Neonatal Medicine, 2005
- Evaluation and Treatment of Neonates With Suspected Late-Onset Sepsis: A Survey of Neonatologists’ PracticesPediatrics, 2002
- Vancomycin and Gentamicin in NeonatesJournal of Perinatal & Neonatal Nursing, 2002
- Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 2002
- Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research NetworkThe Journal of Pediatrics, 1996